There is interest in determining which glp-1 medication is most effective for weight loss. The use of glp-1 medications has reached a new high in the us, but access to these medications, including ozempic, wegovy, and zepbound, is being hindered by certain issues. Additionally, there is ongoing litigation between pharmaceutical companies, including novo nordisk and eli lilly, over advertising claims related to these medications.